Since greater than 80% of strokes occur in individuals over the age of 65, and the elderly have both a higher in-hospital mortality and poorer functional outcomes after an ischemic event [22], it is critical to investigate the therapeutic potential of CD147 inhibition in an aged animal model. Here, BSG is linked to stroke disorder.